The Pharma Mirage
Decoded, Economics & finance

The Pharma Mirage: Measuring Swiss Growth When One Industry Writes the Headlines

Chemicals and pharmaceuticals are 7 percent of Swiss GDP but now drive 37 percent of the variance of quarterly growth. Stripping the industry out shows there was no recession in 2025, that real output per head outside pharma grew only 0.3 percent a year over a decade, and that the 2026 recovery rests on foreign rather than domestic demand.
Continue reading